Evidence map›Paper›PMID 40822361›Full record

ArticleACS catalysis2025

Palladium-Catalyzed Aerobic Alkene Arylboration: Coupling Aryl Boronic Acids, Alkenes, and Bis(pinacol)diboron.

Hoang T P Pham, Shreeja Bhatt, Kami L Hull

Abstract read
In one paragraph

Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Scope and Limitations of the PdClThe Journal of organic chemistry · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hoang T P PhamUniversity of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0002-1844-0085
Shreeja BhattUniversity of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0003-3262-2894
Kami L HullUniversity of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0003-3102-2686

Funding

Transition Metal-Catalyzed Alkene FunctionalizationR35GM125029 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Kami Lee Hull · 2017 to 2026
$2.7M
NIGMS NIH HHS R35 GM125029
6 · The paper itself

Abstract

Alkyl boronic acids and esters are versatile synthetic intermediates that generally require several steps to synthesize. Three-component alkene arylboration reactions allow for the rapid synthesis of alkyl boronic esters. Herein, we report the base-free aerobic Pd-catalyzed three-component alkene arylboration, which allows direct access, in a single step, to alkyl boronic esters from readily available precursors: aryl boronic acids, alkenes, and bis(pinacol)diboron. This approach allows for the formal insertion of an alkene into an Ar-B bond, and thus, generates an alkyl boronic ester from an aryl boronic acid. The reaction proceeds with both electron-rich and electron-deficient aryl boronic acids as well as strained cyclic, internal, and terminal olefins. The reactions are regioselective: 1,2-arylboration products are formed with strained cyclic alkenes and β-alkyl-styrenes while 1,1-arylboration products are generated from terminal alkenes. Forty-five examples are presented with isolated yields of the resulting alkyl boronic esters ranging from 20-74%, along with several examples demonstrating the synthetic utility of the products. Mechanistic investigations support that the catalytic cycle occurs through direct arylboration of the alkene. Further, π-benzyl intermediates form when possible, and the rate of borylation is increased with electron-rich arenes relative to electron-poor. Finally, we demonstrate that aryl boroxines, generated

Indexed as

aerobic oxidationarylborationbase-free transmetalationchain-walkingPalladium catalysisthree-component alkene functionalization

Identifiers

PMID40822361
PMCPMC12356176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.